Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bridging the translational gap in radiotherapy: a human three-dimensional cell culture for evaluating neutron biological effects.

Scientific reports·2026
Same author

CXCL12-abundant reticular cell lineage is the key source of endosteal osteoblasts and adipocytes in adult bone marrow.

Regenerative therapy·2026
Same author

Effects of graft materials on bone regeneration using the osseous shell technique: an experimental study in rats.

International journal of implant dentistry·2026
Same author

Investigation of cartilage modification for controlling immune reaction against xenogeneic cartilage.

Regenerative therapy·2026
Same author

Defining subcellular synovial responses in TMJ osteoarthritis onset via mechanical stress and articular disk derangement models.

International journal of oral science·2026
Same author

Bone marrow endosteum houses Hedgehog-susceptible Dlx5-expressing osteoblast precursor cells.

Communications biology·2026

Related Experiment Video

Updated: Jul 1, 2026

A Lab-On-A-Chip Platform for Stimulating Osteocyte Mechanotransduction and Analyzing Functional Outcomes of Bone Remodeling
08:28

A Lab-On-A-Chip Platform for Stimulating Osteocyte Mechanotransduction and Analyzing Functional Outcomes of Bone Remodeling

Published on: May 21, 2020

Development of high-throughput screening system for osteogenic drugs using a cell-based sensor.

Hironori Hojo1, Kazuyo Igawa, Shinsuke Ohba

  • 1Japan Society for the Promotion of Science, 8 Ichibancho, Chiyoda-ku, Tokyo 102-8472, Japan.

Biochemical and Biophysical Research Communications
|September 16, 2008
PubMed
Summary

Researchers developed a novel cell system to screen for bone-building compounds. This system identified glabrisoflavone (GI), a compound that effectively promotes osteogenic differentiation, offering potential for osteoporosis treatment.

More Related Videos

Using Real-Time Cell Metabolic Flux Analyzer to Monitor Osteoblast Bioenergetics
09:43

Using Real-Time Cell Metabolic Flux Analyzer to Monitor Osteoblast Bioenergetics

Published on: March 1, 2022

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Related Experiment Videos

Last Updated: Jul 1, 2026

A Lab-On-A-Chip Platform for Stimulating Osteocyte Mechanotransduction and Analyzing Functional Outcomes of Bone Remodeling
08:28

A Lab-On-A-Chip Platform for Stimulating Osteocyte Mechanotransduction and Analyzing Functional Outcomes of Bone Remodeling

Published on: May 21, 2020

Using Real-Time Cell Metabolic Flux Analyzer to Monitor Osteoblast Bioenergetics
09:43

Using Real-Time Cell Metabolic Flux Analyzer to Monitor Osteoblast Bioenergetics

Published on: March 1, 2022

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Osteoporosis and bone-loss disorders require novel therapeutics that stimulate bone formation.
  • Existing methods for monitoring osteogenic differentiation can be invasive or imprecise.

Purpose of the Study:

  • To establish a sensitive and noninvasive monitoring system for osteogenic differentiation.
  • To screen compound libraries for novel osteogenic agents using the developed system.

Main Methods:

  • Established MC3T3E1 pre-osteoblastic cells stably transfected with a GFP reporter gene under the rat type I collagen promoter (Col1a1GFP-MC3T3E1).
  • Selected a clone exhibiting fluorescence upon BMP2-induced osteogenic stimulation.
  • Validated GFP fluorescence against alkaline phosphatase (ALP) staining and osteocalcin (Oc) mRNA levels.
  • Screened natural and synthetic compound libraries using the Col1a1GFP-MC3T3E1 system.

Main Results:

  • The Col1a1GFP-MC3T3E1 system demonstrated a strong correlation between GFP fluorescence intensity and established osteogenic markers (ALP, Oc mRNA).
  • Screening identified glabrisoflavone (GI), an isoflavone derivative, as a potent inducer of osteogenic differentiation.
  • Glabrisoflavone (GI) dose-dependently increased ALP staining and Oc mRNA expression.

Conclusions:

  • The Col1a1GFP-MC3T3E1 reporter system provides a reliable and noninvasive method for detecting osteogenic activity.
  • Glabrisoflavone (GI) is a promising candidate compound for treating bone-loss disorders.
  • The developed reporter system is valuable for the discovery of novel osteogenic drugs.